These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 28540980)
1. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer. Zeng Z; Chen X; Zhu D; Luo Z; Yang M Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980 [TBL] [Abstract][Full Text] [Related]
2. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678 [TBL] [Abstract][Full Text] [Related]
3. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Svoboda M; Sana J; Redova M; Navratil J; Palacova M; Fabian P; Slaby O; Vyzula R Diagn Pathol; 2012 Mar; 7():31. PubMed ID: 22439831 [TBL] [Abstract][Full Text] [Related]
4. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer. Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605 [TBL] [Abstract][Full Text] [Related]
5. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. He R; Liu P; Xie X; Zhou Y; Liao Q; Xiong W; Li X; Li G; Zeng Z; Tang H J Exp Clin Cancer Res; 2017 Oct; 36(1):145. PubMed ID: 29037220 [TBL] [Abstract][Full Text] [Related]
6. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes. Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749 [TBL] [Abstract][Full Text] [Related]
7. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer. Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653 [TBL] [Abstract][Full Text] [Related]
8. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer. Thakur S; Grover RK; Gupta S; Yadav AK; Das BC PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381 [TBL] [Abstract][Full Text] [Related]
9. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells. Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384 [TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-34 family low expression correlates with poor prognosis in patients with non-small cell lung cancer. Zhao K; Cheng J; Chen B; Liu Q; Xu D; Zhang Y J Thorac Dis; 2017 Oct; 9(10):3735-3746. PubMed ID: 29268381 [TBL] [Abstract][Full Text] [Related]
11. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464 [TBL] [Abstract][Full Text] [Related]
12. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status. Shen S; Sun Q; Liang Z; Cui X; Ren X; Chen H; Zhang X; Zhou Y PLoS One; 2014; 9(6):e100664. PubMed ID: 24945253 [TBL] [Abstract][Full Text] [Related]
13. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a. Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of microRNAs in triple-negative breast cancer. Paszek S; Gabło N; Barnaś E; Szybka M; Morawiec J; Kołacińska A; Zawlik I Ginekol Pol; 2017; 88(10):530-536. PubMed ID: 29192413 [TBL] [Abstract][Full Text] [Related]
15. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma. Daugaard I; Knudsen A; Kjeldsen TE; Hager H; Hansen LL Exp Mol Pathol; 2017 Jun; 102(3):484-491. PubMed ID: 28512015 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer. Jang MH; Kim HJ; Gwak JM; Chung YR; Park SY Hum Pathol; 2017 Oct; 68():69-78. PubMed ID: 28882698 [TBL] [Abstract][Full Text] [Related]
17. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
18. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers. Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640 [TBL] [Abstract][Full Text] [Related]
19. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer. Hiyoshi Y; Schetter AJ; Okayama H; Inamura K; Anami K; Nguyen GH; Horikawa I; Hawkes JE; Bowman ED; Leung SY; Harris CC PLoS One; 2015; 10(4):e0124899. PubMed ID: 25894979 [TBL] [Abstract][Full Text] [Related]
20. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]